We are live on ! Find out more
DARE icon

Dare Bioscience
DARE

30 hedge funds and large institutions have $5.82M invested in Dare Bioscience in 2022 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 11 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 3

0.08% less ownership

Funds ownership: 0.77% → 0.69% (-0.08%)

3% less funds holding

Funds holding: 31 → 30 (-1)

55% less capital invested

Capital invested by funds: $12.8M → $5.82M (-$7.01M)

64% less repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 11

Holders
30
Holders Change
-1
Holders Change %
-3.23%
% of All Funds
0.48%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
3
Increased
4
Reduced
11
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$46.6K
2
Jane Street
Jane Street
New York
+$20.6K
3
VF
Virtu Financial
New York
+$8.6K
4
BlackRock
BlackRock
New York
+$7.47K
5
Vanguard Group
Vanguard Group
Pennsylvania
+$1.75K

Top Sellers

Rank Fund Capital Flow
1
SAM
Soviero Asset Management
New York
-$298K
2
FFS
Founders Financial Securities
Maryland
-$218K
3
Renaissance Technologies
Renaissance Technologies
New York
-$139K
4
Millennium Management
Millennium Management
New York
-$48.2K
5
UBS Group
UBS Group
Switzerland
-$26.6K
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$2.93M +$1.75K +157 +0.1%
Geode Capital Management
2
Geode Capital Management
Massachusetts
$678K -$1.77K -158 -0.2%
BlackRock
3
BlackRock
New York
$595K +$7.47K +668 +1%
Renaissance Technologies
4
Renaissance Technologies
New York
$416K -$139K -12,443 -23%
State Street
5
State Street
Massachusetts
$188K – – –
SAM
6
Soviero Asset Management
New York
$149K -$298K -26,667 -64%
Northern Trust
7
Northern Trust
Illinois
$134K – – –
T. Rowe Price Associates
8
T. Rowe Price Associates
Maryland
$104K – – –
Millennium Management
9
Millennium Management
New York
$101K -$48.2K -4,315 -30%
FFS
10
Founders Financial Securities
Maryland
$94.6K -$218K -19,485 -67%
VF
11
Virtu Financial
New York
$64K +$8.6K +769 +14%
Morgan Stanley
12
Morgan Stanley
New York
$56.1K +$46.6K +4,166 +283%
IVM
13
InterWest Venture Management
California
$51.5K – – –
Commonwealth Equity Services
14
Commonwealth Equity Services
Massachusetts
$36K – – –
Charles Schwab
15
Charles Schwab
California
$25.3K – – –
RJFSA
16
Raymond James Financial Services Advisors
Florida
$24.9K – – –
Susquehanna International Group
17
Susquehanna International Group
Pennsylvania
$24.1K -$11.7K -1,045 -30%
UBS Group
18
UBS Group
Switzerland
$23.2K -$26.6K -2,381 -51%
Bank of New York Mellon
19
Bank of New York Mellon
New York
$21.5K – – –
Jane Street
20
Jane Street
New York
$18.4K +$20.6K +1,847 New
HighTower Advisors
21
HighTower Advisors
Illinois
$17K -$4.97K -445 -21%
UCFA
22
United Capital Financial Advisors
Texas
$13.1K – – –
TRCT
23
Tower Research Capital (TRC)
New York
$13K -$9.11K -815 -39%
ASN
24
Advisory Services Network
Georgia
$12.4K – – –
Osaic Holdings
25
Osaic Holdings
Arizona
$12K -$10.3K -917 -44%
1
2

DARE Hedge Fund Activity: Q4 2022 in Review

30 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Dare Bioscience (DARE) for Q4 2022, worth a combined $5.82M — down 55% from $12.8M a quarter earlier.

Fund positioning in DARE was balanced in Q4 2022: 3 funds opened new positions, 3 closed out, 4 added to existing stakes and 11 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $46.6K. The largest seller was Soviero Asset Management, cutting an estimated $298K.

  • 30 institutional investors held Dare Bioscience (DARE) as of Q4 2022, down from 31 in Q3 2022.
  • Funds reported $5.82M of Dare Bioscience stock for Q4 2022, down 55% quarter-over-quarter.
  • 3 funds opened new Dare Bioscience positions in Q4 2022 and 3 closed out, a net change of 0 holders.
  • The largest Dare Bioscience buyer in Q4 2022 was Morgan Stanley, an estimated $46.6K added.
  • The largest Dare Bioscience seller in Q4 2022 was Soviero Asset Management, an estimated $298K sold.

Based on aggregated 13F filings for Q4 2022.